These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 6149134)

  • 1. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
    Rezvani A; Way EL
    Eur J Pharmacol; 1984 Jul; 102(3-4):475-9. PubMed ID: 6149134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Löh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):71-9. PubMed ID: 6123594
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-endorphin fragments DTgammaE and DEgammaE reduced morphine inhibition of electrically-induced contractions and opiate withdrawal.
    Capasso A
    Med Chem; 2009 Mar; 5(2):165-70. PubMed ID: 19275715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A characterization of dynorphin-(1-13) on the guinea pig ileal longitudinal muscle.
    Vaught JL
    Eur J Pharmacol; 1981 Dec; 76(4):453-6. PubMed ID: 6276199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal responses of guinea-pig isolated ileum following brief exposure to opiates and opioid peptides.
    Chahl LA
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):387-92. PubMed ID: 2430191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.
    Yoshimura K; Huidobro-Toro JP; Way EL
    Eur J Pharmacol; 1982 Oct; 84(1-2):17-24. PubMed ID: 6128236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin is a specific endogenous ligand of the kappa opioid receptor.
    Chavkin C; James IF; Goldstein A
    Science; 1982 Jan; 215(4531):413-5. PubMed ID: 6120570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The choice of opiate receptor subtype by neo-endorphins.
    Oka T; Negishi K; Kajiwara M; Watanabe Y; Ishizuka Y; Matsumiya T
    Eur J Pharmacol; 1982 Apr; 79(3-4):301-5. PubMed ID: 6284522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesia induced by intrathecal injection of dynorphin B in the rat.
    Han JS; Xie GX; Goldstein A
    Life Sci; 1984 Apr; 34(16):1573-9. PubMed ID: 6371415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T; Aoki K; Kajiwara M
    Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea-pig oesophagus.
    Kamikawa Y; Shimo Y
    Br J Pharmacol; 1983 Apr; 78(4):693-9. PubMed ID: 6303485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of K-opiate sites by dynorphin in the myenteric plexus.
    Yoshimura K; Huidobro-Toro JP; Lee NM; Loh HH; Way EL
    Adv Biochem Psychopharmacol; 1982; 33():91-8. PubMed ID: 6127009
    [No Abstract]   [Full Text] [Related]  

  • 16. On the opioid receptor subtype inhibiting the evoked release of 3H-noradrenaline from guinea-pig atria in vitro.
    Fuder H; Buder M; Riers HD; Rothacher G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):148-55. PubMed ID: 2871496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    Cox BM; Chavkin C
    Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible modulatory role of dynorphin on the excitation by neurotensin on the guinea pig myenteric plexus.
    Huidobro-Toro JP; Way EL
    Neurosci Lett; 1982 Jun; 30(3):309-14. PubMed ID: 7110637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of opioid receptor types on post-tetanic twitch inhibition in isolated guinea-pig ileal longitudinal muscle.
    Ozaki M; Miyamoto Y; Kishioka S; Masuda Y; Yamamoto H
    Neuropharmacology; 1994 May; 33(5):671-9. PubMed ID: 7936103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.